Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Urologia Internationalis
|
July 31, 2024
Refluxing versus Non-Refluxing Ureteric Implantation in Continent Cutaneous Urinary Diversion: A Propensity-Scored Comparison regarding Long-Term Renal, Metabolic, and Functional Outcomes of Patients with Ileocecal Pouch
Marcel Schwinger, Anna Katharina Seitz, Hubert Kübler, et al.
Urologia Internationalis
|
August 18, 2024
A Propensity Score-Based Comparison regarding Renal, Functional, and Surgical Outcome of Continent Cutaneous Urinary Diversions in Patients with Benign Chronic Bladder Diseases and Patients with Bladder Cancer
Vincent Scheper, Anna Katharina Seitz, Hubert Kübler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2019
False-negative <sup>18</sup>F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake
Philipp E Hartrampf, Anna Katharina Seitz, Markus Krebs, et al.
Urologic Oncology
|
February 4, 2023
Preliminary results regarding automated identification of patients with a limited six-month survival prognosis using nursing assessment in uro-oncology patients
Carmen Roch, Julian Alexander Kielkopf, Ulrich Stefenelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 18, 2020
Prognostic implications of dual tracer PET/CT: PSMA ligand and [<sup>18</sup>F]FDG PET/CT in patients undergoing [<sup>177</sup>Lu]PSMA radioligand therapy
Kerstin Michalski, Juri Ruf, Christian Goetz, et al.
World Journal of Urology
|
May 28, 2013
The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancer
Thomas Horn, Barbara Ladwein, Tobias Maurer, et al.
Biomedicines
|
November 21, 2020
Detection Rate of <sup>68</sup>Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy
Joachim Brumberg, Melanie Beckl, Alexander Dierks, et al.
Urologia Internationalis
|
April 28, 2026
Routine Retrograde Conduitography after Radical Cystectomy for Bladder Cancer: Diagnostic Yield and Clinical Impact
Vincent Scheper, Lea Berninger, Marcel Schwinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 2, 2026
Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis
Natalie Hasenauer, Charlotte Probst, Wiebke Schloetelburg, et al.
Cancers
|
September 10, 2021
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [<sup>177</sup>Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome
Philipp E Hartrampf, Constantin Lapa, Sebastian E Serfling, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Urologia Internationalis
|
July 31, 2024
Refluxing versus Non-Refluxing Ureteric Implantation in Continent Cutaneous Urinary Diversion: A Propensity-Scored Comparison regarding Long-Term Renal, Metabolic, and Functional Outcomes of Patients with Ileocecal Pouch
Marcel Schwinger, Anna Katharina Seitz, Hubert Kübler, et al.
Urologia Internationalis
|
August 18, 2024
A Propensity Score-Based Comparison regarding Renal, Functional, and Surgical Outcome of Continent Cutaneous Urinary Diversions in Patients with Benign Chronic Bladder Diseases and Patients with Bladder Cancer
Vincent Scheper, Anna Katharina Seitz, Hubert Kübler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2019
False-negative <sup>18</sup>F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake
Philipp E Hartrampf, Anna Katharina Seitz, Markus Krebs, et al.
Urologic Oncology
|
February 4, 2023
Preliminary results regarding automated identification of patients with a limited six-month survival prognosis using nursing assessment in uro-oncology patients
Carmen Roch, Julian Alexander Kielkopf, Ulrich Stefenelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 18, 2020
Prognostic implications of dual tracer PET/CT: PSMA ligand and [<sup>18</sup>F]FDG PET/CT in patients undergoing [<sup>177</sup>Lu]PSMA radioligand therapy
Kerstin Michalski, Juri Ruf, Christian Goetz, et al.
World Journal of Urology
|
May 28, 2013
The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancer
Thomas Horn, Barbara Ladwein, Tobias Maurer, et al.
Biomedicines
|
November 21, 2020
Detection Rate of <sup>68</sup>Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy
Joachim Brumberg, Melanie Beckl, Alexander Dierks, et al.
Urologia Internationalis
|
April 28, 2026
Routine Retrograde Conduitography after Radical Cystectomy for Bladder Cancer: Diagnostic Yield and Clinical Impact
Vincent Scheper, Lea Berninger, Marcel Schwinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 2, 2026
Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis
Natalie Hasenauer, Charlotte Probst, Wiebke Schloetelburg, et al.
Cancers
|
September 10, 2021
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [<sup>177</sup>Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome
Philipp E Hartrampf, Constantin Lapa, Sebastian E Serfling, et al.
Page
of 4